Interventions for Tuberculosis Control and Elimination 2002

1165. Oleksijew A, Meulbroek J, Ewing P, Jarvis K, Mitten M, Paige L, Tovcimak A,
Nukkula M, Chu D, Alder JD. In vivo efficacy of ABT-255 against drugsensitive
and -resistant Mycobacterium tuberculosis strains. Antimicrob Agents
Chemother 1998; 42: 2674-7.
1166. Cynamon MH, Klemens SP, Sharpe CA, Chase S. Activities of several novel
oxazolidinones against Mycobacterium tuberculosis in a murine model.
Antimicrob Agents Chemother 1999; 43: 1189-91.
1167. Eustice DC, Feldman PA, Zajac I, Slee AM. Mechanism of action of DuP 721:
inhibition of an early event during initiation of protein synthesis. Antimicrob
Agents Chemother 1988; 32: 1218-22.
1168. Lin AH, Murray RW, Vidmar TJ, Marotti KR. The oxazolidinone eperezolid
binds to the 50S ribosomal subunit and competes with binding of chloramphenicol
and lincomycin. Antimicrob Agents Chemother 1997; 41: 2127-31.
1169. Coffey GL, Anderson LE, Fisher MW, Galbraith MM, Hillegas AB,
Kohberger DL, Thompson PA, Weston KS, Ehrlich J. Biological studies of
paromomycin. Antibiotica et Chemotherapia 1959; 9: 730-80.
1170. Gilbert DN. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, Eds.
Principles and practice of infectious diseases. New York: Churchill Livingstone,
2000; 307-336.
1171. Donald PR, Sirgel FA, Kanyok TP, Danziger LH, Venter A, Botha FJ, Parkin DP,
Seifart HI, Van de Wal BW, Maritz JS, Mitchison DA. Early bactericidal activity
of paromomycin (aminosidine) in patients with smear-positive pulmonary
tuberculosis. Antimicrob Agents Chemother 2000; 44: 3285-7.
1172. Kristiansen JE, Amaral L. The potential management of resistant infections
with non-antibiotics. J Antimicrob Chemother 1997; 40: 319-27.
1173. Amaral L, Kristiansen JE. Phenothiazines: an alternative to conventional therapy
for the initial management of suspected multidrug resistant tuberculosis. A
call for studies. Int J Antimicrob Agents 2000; 14: 173-6.
1174. Kristiansen JE, Vergmann B. The antibacterial effect of selected phenothiazines
and thioxanthines on slow-growing mycobacteria. Acta Pathol Microbiol
Immunolog Scand Sect B 1986; 94: 393-8.
1175. Chakrabarty AN, Bhattacharya CP, Dastidar SG. Antimycobacterial activity of
methidilazine (Md), an antimicrobic phenothiazine. APMIS 1993; 101: 449-54.
1176. Amaral L, Kristiansen JF, Abebe LS, Millett W. Inhibition of the respiration
of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thoridazine:
potential use for initial therapy of freshly diagnosed tuberculosis. J
Antimicrob Chemother 1996; 38: 1049-53.
1177. Viveiros M, Amaral L. Enhancement of antibiotic activity against poly-drug
resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents
2001; 17: 225-8.
248